Handa Pharmaceuticals, Inc. (6620)
TWSE
Closed
Oct 2, 2026
Day's Range
142.5052 wk Range
64.10Overview - 6620 - Handa Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
19.63B
P/E (Trailing)
‪46.59‬
P/E (Forward)
‪29.34‬
PEG Ratio
‪29.34‬
Price / Sales (TTM)
‪19.25‬
Price / Book
‪4.64‬
EV / EBITDA
‪32.46‬
Profitability
Gross Margin
‪79.89%‬
Profit Margin
‪40.48%‬
Operating Margin
‪23.24%‬
Return on Assets
‪5.53%‬
Return on Equity
‪10.60%‬
Ownership
Shares Outstanding
162.53M
Float
92.96M
Held by Insiders
‪42.03%‬
Held by Institutions
‪1.25%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪103.00‬
200-Day Avg
‪85.83‬
Dividends
Payout Ratio
‪67.47%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 6620 - Handa Pharmaceuticals, Inc.
Peers - 6620 - Handa Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
- 6620TWSEHanda Pharmaceuticals, Inc.23.32BMarket Cap-3.14%52-week change46.59P/E (Trailing)‪40.48%‬Profit Margin
- 1513TWSEChung-Hsin Electric & Machinery Manufacturing Corp.82.01BMarket Cap+7.53%52-week change18.65P/E (Trailing)‪15.73%‬Profit Margin
- 3030TWSETest Research Inc.63.77BMarket Cap+35.00%52-week change20.49P/E (Trailing)‪32.69%‬Profit Margin
- 1795TWSELotus Pharmaceutical Co., Ltd.46.69BMarket Cap-45.97%52-week change12.34P/E (Trailing)‪13.22%‬Profit Margin
- 4123TWSECenter Laboratories, Inc.23.35BMarket Cap-8.72%52-week change78.00P/E (Trailing)‪61.50%‬Profit Margin
- 4105TWSETTY Biopharm Company Limited19.46BMarket Cap+0.77%52-week change11.25P/E (Trailing)‪26.04%‬Profit Margin
- 3705TWSEYungshin Global Holding Corp.15.10BMarket Cap-1.77%52-week change16.62P/E (Trailing)‪11.42%‬Profit Margin
Profile Summary - 6620 - Handa Pharmaceuticals, Inc.
About
Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Tainan, Taiwan, primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. Established in 2014, the company’s core focus lies in the advancement of niche drugs, particularly the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
